Fig. 2
From: Expect the unexpected: fulminant myocardial cytotoxic Injury from Trabectedin

Laboratory trends for multi-organ involvement from Trabectedin-induced cytotoxicity. (A) Elevated hs-TnI (ng/L) after Tbt initiation and steroid treatment (arrows). (B) Rhabdomyolysis with elevated total CK. (C) Acute renal failure with elevated BUN/Cr. (D) Acute liver failure with elevated AST/ALT